Alyeska Investment Group
AMGN icon

Alyeska Investment Group’s Amgen AMGN Stock Holding History

Alyeska Investment Group’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-210,000
Closed -$56.4M – 518
2023
Q3 		$56.4M Buy
+210,000
New +$52.4M 0.38% 89
2023
Q1 		– Sell
-272,182
Closed -$71.5M – 445
2022
Q4 		$71.5M Buy
+272,182
New +$73M 0.74% 31
2020
Q2 		– Sell
-251,646
Closed -$51M – 472
2020
Q1 		$51M Buy
251,646
+25,540
+11% +$5.58M 1.02% 25
2019
Q4 		$54.5M Buy
226,106
+24,018
+12% +$5.29M 0.72% 43
2019
Q3 		$39.1M Buy
+202,088
New +$38.8M 0.57% 58
2014
Q4 		– Sell
-249,364
Closed -$35M – 478
2014
Q3 		$35M Buy
+249,364
New +$32.6M 0.72% 23
2013
Q4 		– Sell
-25,000
Closed -$2.8M – 300
2013
Q3 		$2.8M Buy
+25,000
New +$2.71M 0.11% 197

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Alyeska Investment Group's AMGN Position: Q4 2023 in Review

Alyeska Investment Group sold out of Amgen (AMGN) in Q4 2023, closing a stake of 210,000 shares — an estimated $56.4M sold.

Alyeska Investment Group first reported a position in AMGN in Q3 2013 and held it in 7 quarters. The position peaked at $71.5M in Q4 2022. 2,714 funds tracked by Wall St. Rank hold AMGN as of Q4 2023.

  • Alyeska Investment Group reported no remaining Amgen position as of Q4 2023 after selling out during the quarter.
  • Alyeska Investment Group sold 210,000 Amgen shares in Q4 2023, an estimated $56.4M.
  • Alyeska Investment Group first reported a position in Amgen in Q3 2013 and held it in 7 quarters.
  • Alyeska Investment Group's Amgen position peaked at $71.5M in Q4 2022.
  • 2,714 funds tracked by Wall St. Rank held Amgen as of Q4 2023.

Based on Alyeska Investment Group's 13F filing for Q4 2023, filed 14 Feb 2024.